north american biologicals inc said has received mln dlr credit facility from manufacturers and traders trust buffalo said new credit would replace existing mln dlr line with barclays plc and due more favorable interest rates borrowing costs should significantly reduced company said half credit designated for acquisitions said expects conclude acquisition possibly outside its plasma and serum field year end reuter 